TY - JOUR T1 - DEep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder AU - Denys D, Mantione M, Figee M, et al Y1 - 2010/10/04 N1 - 10.1001/archgenpsychiatry.2010.122 JO - Archives of General Psychiatry SP - 1061 EP - 1068 VL - 67 IS - 10 N2 - Context  Obsessive-compulsive disorder (OCD) is a chronic psychiatric disorder that affects 2% of the general population. Even when the best available treatments are applied, approximately 10% of patients remain severely afflicted and run a long-term deteriorating course of OCD.Objective  To determine whether bilateral deep brain stimulation of the nucleus accumbens is an effective and safe treatment for treatment-refractory OCD.Design  The study consisted of an open 8-month treatment phase, followed by a double-blind crossover phase with randomly assigned 2-week periods of active or sham stimulation, ending with an open 12-month maintenance phase.Setting  Academic research.Patients  Sixteen patients (age range, 18-65 years) with OCD according to DSM-IV criteria meeting stringent criteria for refractoriness to treatment were included in the study.Interventions  Treatment with bilateral deep brain stimulation of the nucleus accumbens.Main Outcome Measures  Primary efficacy was assessed by score change from baseline on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Responders were defined by a score decrease of at least 35% on the Y-BOCS.Results  In the open phase, the mean (SD) Y-BOCS score decreased by 46%, from 33.7 (3.6) at baseline to 18.0 (11.4) after 8 months (P < .001). Nine of 16 patients were responders, with a mean (SD) Y-BOCS score decrease of 23.7 (7.0), or 72%. In the double-blind, sham-controlled phase (n = 14), the mean (SD) Y-BOCS score difference between active and sham stimulation was 8.3 (2.3), or 25% (P = .004). Depression and anxiety decreased significantly. Except for mild forgetfulness and word-finding problems, no permanent adverse events were reported.Conclusion  Bilateral deep brain stimulation of the nucleus accumbens may be an effective and safe treatment for treatment-refractory OCD.Clinical Trial Registration  isrctn.org Identifier: ISRCTN23255677 SN - 0003-990X M3 - doi: 10.1001/archgenpsychiatry.2010.122 UR - http://dx.doi.org/10.1001/archgenpsychiatry.2010.122 ER -